Market revenue in 2023 | USD 1.3 million |
Market revenue in 2030 | USD 3.1 million |
Growth rate | 12.7% (CAGR from 2023 to 2030) |
Largest segment | Neurology |
Fastest growing segment | Orthopedic |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Dental, Orthopedic, Neurology |
Key market players worldwide | GlaxoSmithKline, Hewlett Packard Enterprise Co, Merck KGaA, AstraZeneca PLC, Aprecia Pharmaceuticals, Extend Biosciences, BioDuro, Affini-T Therapeutics, Osmotica Pharmaceutical, FabRx, Cycle Pharmaceuticals |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to 3d printed drugs market will help companies and investors design strategic landscapes.
Neurology was the largest segment with a revenue share of 53.85% in 2023. Horizon Databook has segmented the Mexico 3d printed drugs market based on dental, orthopedic, neurology covering the revenue growth of each sub-segment from 2018 to 2030.
The significant growth of Mexico's 3D printed drugs market in recent years can be attributed to several key factors, such as the rising demand for personalized medical solutions, which has increased the adoption of 3D printed drugs. In addition, the increasing prevalence of chronic diseases has created a high demand for 3D printed drugs.
A prominent characteristic of Mexico's demographic shift is the rapid growth of its elderly population. As per United Nations data from 2020, the population aged 60 and above has reached 14.5 million, constituting 11% of the total population.
Women account for 55% and men comprise 45% of this age group. In addition, projections indicate that by 2050, one in every four individuals in Mexico will be 60 or older, equating to approximately 40 million people. This demographic shift highlights the increasing healthcare needs and the demand for innovative solutions such as 3D printed drugs.
Horizon Databook provides a detailed overview of country-level data and insights on the Mexico 3d printed drugs market , including forecasts for subscribers. This country databook contains high-level insights into Mexico 3d printed drugs market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account